Delcath system 2 - la vendetta
- Creatore Discussione komodo1001
- Data di inizio
ma nooooooooooooooooooooooooooooooooooooooooo
Non ho capito...ho sbagliato?
Miki & Varenne
Nuovo Utente
- Registrato
- 18/6/09
- Messaggi
- 48.694
- Punti reazioni
- 332
mah ieri e l'altro si blokkava e andava in blackout x 10/15 minuti oggi va meglio
Lo chiedo anche a te ho sbagliato a vendere delcath per entrare su avinger
Miki & Varenne
Nuovo Utente
- Registrato
- 18/6/09
- Messaggi
- 48.694
- Punti reazioni
- 332
Miki & Varenne
Nuovo Utente
- Registrato
- 18/6/09
- Messaggi
- 48.694
- Punti reazioni
- 332
Non ho capito però se è una domanda la tua ...
Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments
GlobeNewswire•April 18, 2017
NEW YORK, April 18, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, commended Spire Southampton Hospital on the performance of over 100 percutaneous hepatic perfusion (PHP®) procedures with CHEMOSAT®. PHP with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver. The product is commercially available in Europe under the trade name CHEMOSAT, and is being evaluated as an investigational therapy in the U.S. Delcath is currently enrolling patients in the FOCUS trial, a global Phase 3 clinical trial that is investigating PHP with Melphalan/HDS as a treatment for patients with ocular melanoma that has metastasized to the liver.
PHP is a minimally invasive procedure that isolates the liver from the body’s circulatory system, so that a high dose of chemotherapy (melphalan hydrochloride) may be infused directly into the liver with the potential to treat both visualized and non-visualized metastases. Blood from the liver is then filtered to remove the chemotherapeutic agent thereby minimizing systemic exposure and potentially the associated side effects.
As part of the Spire Southampton’s celebration of this milestone, a hospital statement highlighted the case of Brian Carney, a retired businessman from Leeds, UK. Mr. Carney was initially diagnosed with ocular melanoma in 2005, and in 2013 physicians discovered the disease had metastasized to his liver. Prognosis after ocular melanoma has metastasized in the liver is poor with a median survival of six months. In the case of Mr. Carney, he was referred to Spire Southampton, and received his first PHP treatment in December 2013. In the intervening period, he has also undergone liver resections and immunotherapy treatments. He recently became the first patient in the world to receive eight PHP treatments, which controlled the tumor and allowed him to conduct normal daily activities at his home. Mr. Carney remains under the care of Spire Southampton where his condition is regularly checked between therapies.
About Spire Southampton
Spire Southampton Hospital is a leading independent hospital group in the United Kingdom with 38 hospitals and 12 clinics across England, Wales and Scotland. The hospital is a leading CHEMOSAT-treatment center, performing the highest number of recorded PHP treatments in the world.
GlobeNewswire•April 18, 2017
NEW YORK, April 18, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, commended Spire Southampton Hospital on the performance of over 100 percutaneous hepatic perfusion (PHP®) procedures with CHEMOSAT®. PHP with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver. The product is commercially available in Europe under the trade name CHEMOSAT, and is being evaluated as an investigational therapy in the U.S. Delcath is currently enrolling patients in the FOCUS trial, a global Phase 3 clinical trial that is investigating PHP with Melphalan/HDS as a treatment for patients with ocular melanoma that has metastasized to the liver.
PHP is a minimally invasive procedure that isolates the liver from the body’s circulatory system, so that a high dose of chemotherapy (melphalan hydrochloride) may be infused directly into the liver with the potential to treat both visualized and non-visualized metastases. Blood from the liver is then filtered to remove the chemotherapeutic agent thereby minimizing systemic exposure and potentially the associated side effects.
As part of the Spire Southampton’s celebration of this milestone, a hospital statement highlighted the case of Brian Carney, a retired businessman from Leeds, UK. Mr. Carney was initially diagnosed with ocular melanoma in 2005, and in 2013 physicians discovered the disease had metastasized to his liver. Prognosis after ocular melanoma has metastasized in the liver is poor with a median survival of six months. In the case of Mr. Carney, he was referred to Spire Southampton, and received his first PHP treatment in December 2013. In the intervening period, he has also undergone liver resections and immunotherapy treatments. He recently became the first patient in the world to receive eight PHP treatments, which controlled the tumor and allowed him to conduct normal daily activities at his home. Mr. Carney remains under the care of Spire Southampton where his condition is regularly checked between therapies.
About Spire Southampton
Spire Southampton Hospital is a leading independent hospital group in the United Kingdom with 38 hospitals and 12 clinics across England, Wales and Scotland. The hospital is a leading CHEMOSAT-treatment center, performing the highest number of recorded PHP treatments in the world.
The Miracle
The game never ends
- Registrato
- 17/9/00
- Messaggi
- 13.406
- Punti reazioni
- 966
Però il reverse ( fino ad 1:500 ) verrà approvato oggi.. quindi io mi do alla fuga senza un misero cent di gain.
Pablo.Escobar
Nuovo Utente
- Registrato
- 7/3/16
- Messaggi
- 5.049
- Punti reazioni
- 39
Non la sto più seguendo.. È un pump pre rs?
In otc gbsn ha fatto una mega corsa, mai dire mai anche qui
In otc gbsn ha fatto una mega corsa, mai dire mai anche qui
komodo1001
Nuovo Utente
- Registrato
- 3/9/10
- Messaggi
- 2.050
- Punti reazioni
- 23
death spiral financing .. stop!
komodo1001
Nuovo Utente
- Registrato
- 3/9/10
- Messaggi
- 2.050
- Punti reazioni
- 23
ma uno spike da +300% prima di morire dovra farlo, non puo non farlo!
Infatti tutti hanno diritto all'ultimo Spike prima della morte.
komodo1001
Nuovo Utente
- Registrato
- 3/9/10
- Messaggi
- 2.050
- Punti reazioni
- 23
io su sto titolo ci ho fatto davvero un azzardo .. se mi andava bene mi ritiravo a vita .. è andata male e si è magnata tutto .. altro che roulette .. qua si lambisce la truffa .. L'intero fatturato, 2mln di dollari serve solo a pagare gli stipendi dei tre capetti delcath .. da notare 2 mln di fatturato dopo 15 anni di attività .. un successone
Seneca71
Free connections, expand your social circle
- Registrato
- 10/5/07
- Messaggi
- 12.512
- Punti reazioni
- 417
Ho letto x caso...stesso film di Free....mi dicevo "uno spike non può non farlo " e infatti non l'ha fatto e così mi sono mangiato i guadagni di due anni fortunati di borsa 
Comunque dai è bello sognare ma i miracoli in borsa sono sempre meno.
Comunque dai è bello sognare ma i miracoli in borsa sono sempre meno.
Ho letto x caso...stesso film di Free....mi dicevo "uno spike non può non farlo " e infatti non l'ha fatto e così mi sono mangiato i guadagni di due anni fortunati di borsa
Comunque dai è bello sognare ma i miracoli in borsa sono sempre meno.
letto anche io per puro caso(su st continuano a pomparla e spammare)
ma vedo che addirittura è scesa sotto 0,05?
quindi il vecchio floor?
